Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Integrated Biopharma Inc (INBP)

Integrated Biopharma Inc (INBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 ACCESSWIRE - Fri Sep 20, 12:40PM CDT

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.

INBP : 0.2280 (unch)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2024 ACCESSWIRE - Fri Sep 20, 12:00PM CDT

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.

INBP : 0.2280 (unch)
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024 ACCESSWIRE - Fri May 10, 11:30AM CDT

HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024.

INBP : 0.2280 (unch)
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023 ACCESSWIRE - Thu Nov 9, 2023

HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023.

INBP : 0.2280 (unch)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023 ACCESSWIRE - Fri Sep 15, 2023

HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023.

INBP : 0.2280 (unch)
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023 ACCESSWIRE - Thu May 11, 2023

HILLSIDE, NJ / ACCESSWIRE / May 11, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2023.

INBP : 0.2280 (unch)
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022 ACCESSWIRE - Fri Feb 10, 2023

HILLSIDE, NJ / ACCESSWIRE / February 10, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2022.

INBP : 0.2280 (unch)
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022 ACCESSWIRE - Thu Nov 10, 2022

HILLSIDE, NJ / ACCESSWIRE / November 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2022.

INBP : 0.2280 (unch)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022 ACCESSWIRE - Tue Sep 13, 2022

HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2022.

INBP : 0.2280 (unch)
Integrated BioPharma Announces Change in Directors AccessWire - Tue Jun 21, 2022

HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Board...

INBP : 0.2280 (unch)

Barchart Exclusives

Does Your Portfolio Have Room for a 79% 5-Year Track Record ETF? Barchart - 52 minutes ago
Equity investors often overlook market seasonality. Unfortunately, seasonality is usually tied to future markets. However, there are instances where the seasonality of commodities can enhance an Exchange-Traded Fund (ETF). Two significant commodities are entering a seasonal buy that will impact an outperforming homebuilder ETF. The Federal Reserve (FED) appears ready to begin a new cycle of lower rates, which may catalyze this ETF seasonal pattern. Does Your Portfolio Have Room for a 79% 5-Year Track Record ETF? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot